Ｍ－リボミック（4591）　RIBOMIC presented results of Phase 1/2a Clinical Trial of RBM-007 (SUSHI) in Subjects with Wet Age-Related Macular Degeneration at Two Conferences 2020/02/25
/-
読み込み中…